Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing
This article was originally published in The Gray Sheet
Executive Summary
Attorneys involved with a recent court ruling favoring Vascular Solutions believe the verdict might give manufacturers more latitude to engage in truthful, non-misleading, off-label speech. But caution is necessary.
You may also be interested in...
Experts Expect More Speech Protections From FDA During Trump Admin
The ongoing push for less US FDA regulation of speech that is truthful and not misleading should continue through the next several years, experts say.
Industry Groups Petition To Block FDA Intended-Use Rule
Trade groups say FDA’s redefinition of intended use is an overreach and would pose constitutional problems. The agency has yet to respond to a petition asking for the rule to be withdrawn.
Unlocking Legalities: Gorsuch’s Impact May Be Felt On Free Speech, Preemption
Supreme Court Nominee Judge Neil Gorsuch has ruled favoring device companies on preemption, and in support of an inventor in a device patent case. But experts say the impact he would actually have on the court remains to be seen.